Correlation Between Biotechnology Ultrasector and Davidson Multi-cap

Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Davidson Multi-cap at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Davidson Multi-cap into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Davidson Multi Cap Equity, you can compare the effects of market volatilities on Biotechnology Ultrasector and Davidson Multi-cap and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Davidson Multi-cap. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Davidson Multi-cap.

Diversification Opportunities for Biotechnology Ultrasector and Davidson Multi-cap

-0.11

Correlation Coefficient

Biotechnology Ultrasector  Davidson Multi-cap

Good diversification

The 3 months correlation between Biotechnology and Davidson is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Davidson Multi Cap Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Davidson Multi Cap and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Davidson Multi-cap. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Davidson Multi Cap has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Davidson Multi-cap go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Davidson Multi-cap

Assuming the 90 days horizon Biotechnology Ultrasector is expected to generate 3.46 times less return on investment than Davidson Multi-cap. In addition to that, Biotechnology Ultrasector is 3.01 times more volatile than Davidson Multi Cap Equity. It trades about 0.02 of its total potential returns per unit of risk. Davidson Multi Cap Equity is currently generating about 0.16 per unit of volatility. If you would invest  3,294  in Davidson Multi Cap Equity on August 31, 2024 and sell it today you would earn a total of  237.00  from holding Davidson Multi Cap Equity or generate 7.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Biotechnology Ultrasector Prof  vs.  Davidson Multi Cap Equity

Biotechnology Ultrasector

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biotechnology Ultrasector Profund are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Biotechnology Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Davidson Multi Cap

Risk-Adjusted Performance

12 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Davidson Multi Cap Equity are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Davidson Multi-cap may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Biotechnology Ultrasector and Davidson Multi-cap

The main advantage of trading using opposite Biotechnology Ultrasector and Davidson Multi-cap positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Davidson Multi-cap can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Davidson Multi-cap will offset losses from the drop in Davidson Multi-cap's long position.

The idea behind Biotechnology Ultrasector Profund and Davidson Multi Cap Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..